Analytical Data
-
基因名
crnA
- Application
-
别名
Creatininase
-
种属
Pseudomonas putida
-
表达系统
E. coli
-
标签
N- GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P83772
-
表达区间
1-260aa
-
分子量
55.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of crnA recombinant protein is rooted in the growing interest in understanding the functional role of proteins in various biological processes. crnA, a gene known to encode a protein involved in critical cellular functions, has gained attention for its potential implications in areas such as cellular signaling, metabolism, and disease mechanisms. Research has shown that recombinant proteins can be produced using various expression systems, allowing for detailed functional assays and structural analyses. The ability to generate crnA recombinant protein facilitates the investigation of its interaction with other biomolecules, which can provide insights into its physiological roles and potential therapeutic applications. Furthermore, the exploration of crnA protein has opened avenues for the development of novel biotechnological tools and medicines. As the demand for proteins with specific functions in research and therapeutic contexts increases, understanding the properties and functionalities of crnA through recombinant technology is becoming increasingly significant for advancing molecular biology, biochemistry, and medical science. This research aims to elucidate the structure-function relationships of crnA and its mechanisms of action, which may ultimately lead to innovations in treatment strategies for diseases linked to its functional pathways.












